CBN Found to Cause Physical Dependence Symptoms in Mice Study

A growing number of sleep supplements contain Cannabinol (CBN), a cannabis compound marketed as a natural way to relax and improve rest quality.

CBN has become ubiquitous in the market, appearing in various forms such as gummies, tinctures, and capsules. However, new research from the University of Connecticut warns that repeated exposure to CBN may have unintended consequences.

The study found that mice exposed to CBN repeatedly developed physical dependence symptoms, raising concerns about the long-term safety of using this compound regularly. The findings, published in a recent issue of Drug and Alcohol Dependence, urge consumers to be aware of potential risks associated with repeated use.

CBN is chemically related to THC, another well-known cannabis compound, but generally considered less psychoactive. Despite its milder reputation, the researchers discovered that CBN affects similar biological systems and can produce key signs associated with drug dependence, much like THC.

In experiments conducted on mice, researchers found that twice-daily doses of cannabbinol (CBN) over three consecutive days led to tolerance development, as evidenced by reduced responsiveness to the compound.

As CBN treatment continued, the animals also displayed physical symptoms when the compound was withdrawn, including head twitching and paw fluttering. These movements are similar to those experienced during drug withdrawal in humans. The presence of such symptoms suggests that repeated use of CBN may lead to dependence.

CBN's effects were further linked to those of tetrahydrocannabinol (THC), another cannabis compound known for its psychoactive properties. Mice previously trained to respond to THC exhibited similar reactions when given CBN, indicating a potential overlap in subjective effects between the two compounds.

These findings raise concerns about the long-term safety and efficacy of CBN products, which are increasingly popular despite limited scientific understanding of their risks with repeated use.

The rise in popularity of cannabis sleep gummies has led to widespread promotion of CBN as a sleep aid, but several key questions remain unanswered about its effects on human sleep quality and potential for addiction.

Historical precedent suggests caution when introducing new sleep treatments. Over the past century, numerous medications initially touted as helpful for sleep have been found to carry significant risks of dependence and habit formation.

CBN has shown promise in experiments, displaying anti-inflammatory properties that could be beneficial at lower doses not producing psychoactive effects. However, its potential benefits are overshadowed by concerns about its impact on human health.

During a simulated bacterial challenge, CBN was found to compromise the body's immune defenses, potentially making it easier for infections to develop and cause illness. This raises questions about the safety of using CBN products repeatedly at common doses.

The study's findings highlight concerns about the potential long-term effects of using cannabinol (CBN) products, particularly when consumed repeatedly at common doses.

While the research was conducted on mice and does not directly translate to human dependence or withdrawal, it raises questions about the safety of frequent CBN use. The lack of understanding about dosing and long-term effects makes it difficult to determine the full scope of potential risks.

To mitigate these concerns, experts advise consumers to exercise caution when using CBN products until more research is available, emphasizing that "the message for consumers is simple: buyer beware."